Tag: non-invasive therapy

Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial

This randomized, double-blind, sham-controlled clinical trial assessed the efficacy of low-intensity extracorporeal shockwave therapy (LI-ESWT) in 76 men with vascular erectile dysfunction (ED) unresponsive to phosphodiesterase type 5 inhibitors (PDE5Is). Participants received weekly sessions for four weeks (5000 shocks/session at 0.09 mJ/mm²). At 3 months, the treatment group showed a

Read More »

Enhanced Spinal Therapy: Extracorporeal Shock Wave Therapy for the Spine

This 2020 narrative review examines the application of extracorporeal shock wave therapy (ESWT) in treating various spinal pathologies. The review highlights ESWT’s potential benefits in conditions such as degenerative osteoporotic neuro-spinal pathology, heterotopic ossification due to spinal cord injury, cervical spondylosis, scoliosis, sacroiliitis, and coccydynia. ESWT is noted to upregulate

Read More »

Comparative Effectiveness of Focused Extracorporeal versus Radial Extracorporeal Shockwave Therapy for Knee Osteoarthritis—Randomized Controlled Study

This 2022 randomized controlled trial compared the efficacy of focused extracorporeal shockwave therapy (f-ESWT) and radial extracorporeal shockwave therapy (r-ESWT) in 42 patients with bilateral knee osteoarthritis. Participants received three weekly sessions of either f-ESWT or r-ESWT. Outcomes assessed at baseline, 4 weeks, and 8 weeks post-treatment included pain intensity

Read More »

Comparison of the effects between low- versus medium-energy radial extracorporeal shock wave therapy on knee osteoarthritis: A randomised controlled trial

This 2020 randomized controlled trial evaluated the comparative efficacy of low-energy (0.12 mJ/mm²) versus medium-energy (0.24 mJ/mm²) radial extracorporeal shock wave therapy (rESWT) in 60 patients with knee osteoarthritis (KOA). Participants received 2,000 impulses once weekly for four weeks. Outcomes assessed included pain (VAS), function (WOMAC), and range of motion

Read More »

The efficacy and safety of extracorporeal shockwave therapy in knee osteoarthritis: A systematic review and meta-analysis

This 2020 systematic review and meta-analysis evaluated the efficacy and safety of extracorporeal shockwave therapy (ESWT) in treating knee osteoarthritis (KOA). Analyzing three randomized controlled trials and three cohort studies encompassing 589 patients, the study found that ESWT significantly reduced pain scores at 4, 8, and 12 weeks post-treatment, with

Read More »

Extracorporeal Shock Wave Therapy for the Treatment of Osteoarthritis: A Systematic Review and Meta-Analysis

This 2020 systematic review and meta-analysis evaluated the efficacy and safety of extracorporeal shock wave therapy (ESWT) in treating osteoarthritis (OA). The analysis included randomized controlled trials comparing ESWT with other treatments such as placebo, corticosteroids, hyaluronic acid, medications, ultrasound, kinesiotherapy, moxibustion, acupotomy surgery, platelet-rich plasma, fumigation, and manipulation. ESWT

Read More »

The effect of extracorporeal shock wave therapy on large neurogenic heterotopic ossification in a patient with pontine hemorrhage: A case report and literature review

This 2022 case report describes a 36-year-old male who developed bilateral hip neurogenic heterotopic ossification (NHO) three months after a pontine hemorrhage. Seven months post-onset, he received 10 sessions of extracorporeal shock wave therapy (ESWT) every other day. Post-treatment assessments showed improved hip range of motion, better sitting posture, and

Read More »

The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial

This 2022 randomized clinical trial assessed the efficacy of combining low-intensity extracorporeal shock wave therapy (Li-ESWT) with vacuum erectile device (VED) therapy in 105 diabetic men with erectile dysfunction (ED) unresponsive to phosphodiesterase type 5 inhibitors (PDE5is). Participants were divided into three groups: VED alone, Li-ESWT alone, and combined VED

Read More »

Are Radial Pressure Waves Effective for the Treatment of Moderate or Mild to Moderate Erectile Dysfunction? A Randomized Sham Therapy Controlled Clinical Trial

This 2022 randomized, double-blind, sham-controlled clinical trial assessed the efficacy and safety of radial pressure wave therapy (RPWT) in 80 men with moderate or mild to moderate erectile dysfunction (ED). Participants received six weekly sessions of RPWT or sham therapy, alongside daily sildenafil (25 mg). At six weeks, the mean

Read More »